The short answer
Red and near-infrared light does something real to cells, and the evidence for using it on jaw pain is promising rather than settled. The research has used particular devices at particular wavelengths, powers, doses and treatment sites, on particular conditions. Some of it used lasers, some used LEDs, and a little of it was done at home. What none of it tells you is whether an unrelated panel, used at a distance you picked, delivers anything like the dose that was studied.
If you want to try one at home, the things worth knowing are wavelength, irradiance at a stated working distance, and time, because those three are what determine dose. Most product pages do not publish them together.
I deliver photobiomodulation in my office as part of treatment for jaw and facial pain. I write this page because patients keep asking me which panel to buy, and the pages they find are written by the people selling the panel.
What red and near-infrared light actually does
Light in the red and near-infrared range is absorbed inside cells, and the main absorber that has been identified is an enzyme in the mitochondria called cytochrome c oxidase. That absorption sets off a chain of downstream changes.
That is a mechanism. It is well described and it is not in much dispute. It is also not a result. Whether shining light on your jaw reduces your pain is a different question, answered by trials rather than by biochemistry, and it is the question the rest of this page is about.
One thing from the mechanism work does carry straight into practical advice. Photobiomodulation shows a biphasic dose response: lower light doses stimulate and higher doses inhibit, so more exposure is not reliably better. That is worth holding on to when you are comparing devices on output.
What the evidence shows, and what it does not
The strongest evidence for the jaw
The most relevant published work for what I treat is an updated systematic review of randomized controlled trials of photobiomodulation in temporomandibular disorders. It included 40 studies. Of the 39 that reported pain intensity, 27 reported a reduction compared with control, and 7 of the 15 reporting maximum mouth opening reported greater opening than placebo.
The authors’ own summary is “promising effects on the alleviation of pain and improvement in maximum mouth opening”.
Two honest caveats about that review. It counts studies rather than pooling them, so 27 of 39 is not an effect size and it is not the proportion of patients who improved. And the studies used widely different settings, which is exactly the problem this page is about.
What that evidence actually used
This is the part that gets left out, and it is the reason this page exists.
That review’s conclusion names the settings it associated with benefit: an infrared diode laser at a wavelength between 780 and 980 nanometres, an energy density below 100 joules per square centimetre, an output power of 500 milliwatts or less, and at least six sessions.
It would be convenient to stop there and tell you that the research is all clinical lasers and your panel is something else. That is not what the studies say. The included trials use diode lasers, helium-neon lasers, super-pulsed lasers, and LEDs, and two of them were done by patients at home. Light emitting diodes are an accepted photobiomodulation light source alongside lasers, and their practical advantages include ease of home use, the ability to irradiate a large area at once, and much lower cost per milliwatt.
So the honest line is not laser against LED, and it is not clinic against home. It is this. Every one of those results came from a known device, at a known wavelength and power, held a known distance from a known part of the body, for a known time, on a known condition. Change any of those and you are no longer inside the thing that was studied. A panel on a stand across the room, for as long as you feel like, is several steps outside it.
Two reviews, and where they part company
There is a newer paper, a 2026 systematic review and meta-analysis of 40 randomized controlled trials, which pools the results rather than counting studies. It is the stronger design of the two, and it reported significant pain reduction at the third assessment point, and significant improvement in pain-free opening and maximum assisted opening at the same point.
On the settings, the two papers part company in one place and agree in another, and the difference matters if you are shopping.
Wavelength is where they differ. The earlier review points at 780 to 980 nanometres. The 2026 analysis points at 951 to 1070. A third review, one I keep in my own reference library, suggests a GaAlAs diode at 800 to 900 nanometres. Between them they cover most of the near-infrared band, which tells you the question is open rather than that any of them is wrong.
Power is where they broadly agree. 500 milliwatts or less in the first, under 100 in the second, 100 to 500 in the third. The direction is downward, and that fits the biphasic dose response: past a point, more is not better. If a seller’s pitch is that theirs is the most powerful, the research is pointing the other way.
Dose is where it gets uncomfortable. One of those reviews says under 100 joules per square centimetre, another says under 10. That is a tenfold difference in the number that is supposed to matter most, sitting in two reviews of the same literature. Anyone who gives you a confident home dose is not reading the same papers I am.
What has not been shown
- That a particular retail panel reproduces a particular study result.
- That more light, longer sessions, or more of them works better.
- A settled dose for any condition.
- That any of this substitutes for finding out what is actually wrong.
Home panel or clinic: what is actually different
Four things, in order of how much they matter.
Measurement. In the office I know what device I am using and what settings I am delivering, and I can hold it where I mean to. With a consumer panel you are usually relying on a number the manufacturer printed, at a distance they chose, without independent measurement.
Delivery. A clinical device is applied to a target by somebody aiming it. A panel is a wall of light you sit in front of.
That difference is real, and it is not the same as saying home use cannot work. Two of the studies in that review were home-administered, and they are the reason this page does not tell you to skip the panel and book an appointment. What those studies had, and what buying a panel does not give you, was a defined device delivering a defined dose to a defined place on a defined schedule, worked out by somebody first. The gap is not the room. It is whether anyone decided what you are actually doing.
Diagnosis. The reason somebody is in my chair is that we worked out what is actually happening in the joint first. A panel skips that step, and for jaw pain that step is most of the work.
Cost and convenience. This one favours the panel, honestly and substantially. It is available at 10pm, it does not require an appointment, and over a year it can cost less than a course of anything.
The seven numbers that decide whether a device is any good
Wavelength, in nanometres, with a tolerance. A tolerance tells you how tightly the output is controlled. Two round numbers with no tolerance tell you less than they appear to.
Irradiance, in milliwatts per square centimetre, at a stated distance. An irradiance figure with no distance attached is not a figure. Light falls off fast, and the same panel can honestly claim very different numbers at three inches and at twelve.
The distance that figure was measured at. If the product page gives an irradiance and a session time at different distances, somebody is choosing the flattering number for each.
Treatment area at your actual working distance. A large panel used close covers less than the panel is wide.
Session time, which with irradiance gives you dose.
Dose, in joules per square centimetre. Most consumer devices do not publish it, because they have not published irradiance at a stated distance.
Whether anyone other than the manufacturer measured any of it. An independent irradiance report tells you the figure was checked by somebody with no stake in it. That is a different thing from a manufacturer’s own measurement, and it is uncommon in this category. It still tells you only what the device emits, not what it does for a condition.
Two more that are not numbers. Eye protection: near-infrared is invisible, so how bright it looks tells you nothing about exposure. And warranty and returns, because this is a category full of young companies and because fit and placement are personal.
None of these specifications tells you whether a device helps a condition. They tell you what it emits and whether the manufacturer is being straight with you about it. Those are worth knowing, and they are a different question from whether it works.
How to read a product page without being fooled
“FDA approved” is a claim to check, not a badge. There are three different statuses and sellers mix them up, sometimes on purpose.
Cleared means a specific device went through FDA review for a specific stated use. That is real, it is checkable, and it applies to the stated use and not to everything else the device might be pointed at.
General wellness is a category FDA has addressed in guidance stating that CDRH does not intend to examine low risk general wellness products to determine whether they are devices, or whether they comply with premarket and post-market device requirements. Being in it does not mean FDA has judged the device safe, or judged that it works. It also is not something a seller gets to assert about a whole category. Regulatory status is a per-product question, recorded from product-specific evidence, not a category one.
Approved is what FDA does for drugs and for a small number of high-risk devices, and it generally does not apply to a consumer light panel at all.
So the useful question is not “is it FDA approved”. It is “what exactly is this device’s regulatory status, and can you show me”. Any seller who answers that with the word approved has told you something about themselves.
Watch for clinical evidence borrowed for a consumer device. A citation to a laser study on a page selling an LED panel is doing work the study did not do.
Watch for power figures with no area. Total wattage sounds impressive and tells you nothing about what reaches your skin.
Watch for “more is better”. It is the opposite of what the dose response literature shows.
What I use, in the office and at home
In the office I use an MLS Mphi D5, made by ASA Laser in Italy. It runs two wavelengths together, 808 nanometres continuous and 905 nanometres pulsed, at up to about 1.1 watts average power from the handpiece, with a larger applicator that goes higher. It is a Class IV therapeutic laser, which means it is powerful enough to need eye protection for me, for you, and for anyone else in the room. That is clinical photobiomodulation in Rogers.
Two things follow from that, and they are the honest answer to “is a home panel the same thing”.
The wavelengths are different. Mine runs 808 and 905 nanometres. The RedVive panels I use at home run 635, 670, 810 and 850. That is not a ranking, and I would be overstating the research if I told you one was proven better, because the two systematic reviews on this do not agree with each other about which band matters. It is a difference worth knowing when somebody tells you their panel is what the studies used.
The power is in a different class entirely, and so is the responsibility. A Class IV laser is aimed by somebody trained to aim it, at a target chosen after we worked out what was wrong. It is not better because it is stronger. It is different because somebody is deciding.
At home I use RedVive panels, the 60 and the 300. You should know that the practice has a financial relationship with RedVive: a portion of anything bought through our link comes back to the practice, which is set out on our financial disclosure page. That is true whether or not I would have bought them anyway. I did, and I use them.
Who should not use this
This list is mine, for the clinical laser I use. Treat it as the floor for a home device too, because the same tissue is absorbing the same kind of light.
Eyes are the absolute one. Do not let light reach your eyes or the skin around them, and do not rely on how bright it looks, because near-infrared is invisible. Wavelength-rated eye protection is mandatory in my office for the patient, for me, and for anyone else in the room. If a panel arrives without goggles, that tells you something about the seller.
Do not use it if any of these apply, or ask first: pregnancy; active bleeding in the area you were going to treat; any medication or supplement that makes you photosensitive, and there are more of those than people expect, so check rather than assume; a known or suspected active cancer, particularly anywhere near the area being treated.
One more that is not on any manufacturer’s list. If your jaw or face hurts and nobody has worked out why, a panel is a way of not finding out. Get the diagnosis, then decide.
And plainly: this does not replace sorting out your breathing at night, your sleep or your bite. The money is better spent finding out which of those is the problem.
Common questions
Does an at-home red-light panel help TMJ pain?
Nobody has tested that directly for the panels sold to consumers, so the honest answer is that it has not been shown either way. What has been studied is photobiomodulation delivered with specific devices, at specific wavelengths and powers, held at specific distances from specific tissue. Two systematic reviews of that research find the results promising, and they do not agree with each other on the best settings. If your jaw pain is bad enough to be shopping for a device, the more useful step is finding out what is actually causing it. Our clinical page explains what that involves.
Is a home panel as good as the device you use in the office?
That comparison has not been made in a study, and it depends on numbers most panels do not publish. The practical difference is that in the office I know the device, the setting and where it is pointed, and at home you are relying on a manufacturer’s figure at a distance they chose.
What wavelength should I look for?
Here the research is genuinely unsettled. One systematic review associates benefit with 780 to 980 nanometres. A 2026 meta-analysis of overlapping research reports 951 to 1070 nanometres instead. A device should state its wavelengths with a tolerance, and you should check them against both ranges. Treat any seller who tells you one number is the proven one as being ahead of the evidence.
How long should a session be?
There is no established session length for this, and the dose response is biphasic, meaning low doses stimulate and high doses inhibit. Longer is not reliably better. This is the main reason this page does not give you a home protocol.
Is it safe?
It is generally well tolerated. Use the eye protection, because near-infrared is invisible and how bright it looks tells you nothing about exposure. The contraindications are in the section above.
Are these devices FDA approved?
Approval is a status FDA uses for drugs and a small number of high-risk devices, and it generally does not apply to a consumer light panel. Some light devices are separately cleared for a specific stated use, which is a narrower and checkable thing. Others are sold as general wellness products, a category FDA has said it does not intend to examine, though that is not automatic for a device emitting light. Ask the seller which of the three applies to the exact model, and expect a specific answer.
Can I use this instead of coming in?
If you know what is wrong and you are managing it, a panel is a reasonable thing to add. If you do not know what is wrong, a panel is a way of not finding out.
Where to go from here
If you are in Northwest Arkansas and your jaw, face or head hurts, the in-office version is here: clinical photobiomodulation in Rogers.
For the rest of the library, including how I score evidence and which subjects we treat as against only write about, start at the health optimization library.